We only report results to the ordering clinician. Genetic tests should
always be accompanied by genetic counselling.
To request a genetic analysis, please use one of the forms below.
| Cancer |
| Colon |
HNPCC
(hereditary nonpolyposis colorectal cancer): MLH1, MSH2, MSH6 genes
mutation screen |
| FAP (familial
adenomatous polyposis): APC gene (adenomatous polyposis coli) mutation
screen |
| Multiple
polyposis: MYH gene (MUT Y homolog) mutation screen |
| Peutz-Jeghers
syndrom: gene STK11/LKB1 mutation screen |
| Juvenile
Polypose: SMAD4 and BMPR1A mutation screen |
| Gorlin syndrome:
gen PTCH1 mutation screening |
| Cowden syndrome:
gene PTEN mutation screen |
| Analsis
of tumour tissue: gene KRAS mutation screen |
| Li-Fraumeni
syndrom: gene TP53 |
| Multiple
endocrine neoplasia |
MEN-1 (typically
affects parathyroid, pancreas, and pituitary gland): MEN1 gene (menin)
mutation screen |
|
MEN-2a,2b, FMTC (associated with medullary thyroid carcinoma): RET
gene (RET) mutation screen |
| Primary hyperparathyroidism |
Hyperparathyroidism-Jaw tumor syndrom (HPT-JT syndrom):
gene HRPTJ2/CDC73 mutation screen |
| Metabolism |
| Hyperhomocysteinemia |
Methylentetrahydrofolate
reductase (MTHFR) polymorphism screen (MTHFR c.677 C>T) |
| Cystathionin
b-syntase (CBS) mutation screen (CBS c.833 T > C) |
| Cystathionin
b-syntase (CBS) mutation screen (DNA sequencing) |
| Lactose intolerance (adult–type
hypolactasia) |
Lactase
mutation screen (LCT g.-13910C>T) |
| Thrombosis |
| |
Coagulation
factor II, (prothrombin) polymorphism screen (g. 20210 G>A) |
| Coagulation
factor V Leiden mutation (c.1691 G>A) |
| Sudden Cardiac Death |
| LQTS, Long QT
syndrome |
genes KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 mutation
screen:
(High Resolution Melting Analysis (HRMA)and DNA sequencing
|
| BS, Brugada syndrome |
gene SCN5A mutation screen |
ARVC, Arrythmogenic
Right Ventricular Cardiomyopathy |
genes PKP2, DSP, DSG2, JUP og DSC2 mutation screen |